Promoting HIV prevention among high-risk men in Uganda through self-testing and counseling

Secondary distribution of HIV self-testing by FSW, pre-exposure prophylaxis (PrEP) starter packs and brief counseling to promote PrEP initiation and persistence among high-risk men in Uganda

NIH-funded research Makerere University College of Health Sciences · NIH-10839271

This study is looking to help men who are partners of female sex workers in Uganda by giving them easy access to HIV self-testing kits and PrEP starter packs, along with some friendly advice, to encourage them to know their HIV status and stay safe.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMakerere University College of Health Sciences NIH-funded
Lab location1 site (Kampala, Uganda)
Project IDNIH-10839271 on NIH RePORTER

What this research studies

This research aims to improve HIV prevention efforts in Uganda by distributing HIV self-testing kits from female sex workers (FSWs) to their male partners. The project will also provide pre-exposure prophylaxis (PrEP) starter packs and brief counseling to encourage these men to start and continue using PrEP. By addressing barriers such as stigma and access to healthcare, the intervention seeks to increase awareness of HIV status and promote safer sexual behaviors. The study will focus on understanding how these strategies can enhance PrEP uptake and adherence among high-risk populations.

Who could benefit from this research

Good fit: Ideal candidates for this research are high-risk men, particularly those who are clients of female sex workers in Uganda.

Not a fit: Patients who are not at high risk for HIV or those who are already engaged in effective HIV prevention strategies may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce HIV transmission rates among high-risk men in Uganda.

How similar studies have performed: Previous research has shown promise in using self-testing and peer-led interventions to improve HIV prevention, indicating that this approach may be effective.

Where this research is happening

Kampala, Uganda

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.